
Number of publications published per year by Onori, Paolo. (Source : PubMed)

Distribution of publications types for Onori, Paolo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma.
Int. J. Cancer
2010;126;9

After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.
Am. J. Pathol.
2010;176;4

Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.
Dig Liver Dis
2010;42;4

Polycystic liver diseases.
Dig Liver Dis
2010;42;4
Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.
Dig Liver Dis
2010
Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor.
Int. J. Cancer
2009
Polycystins play a key role in the modulation of cholangiocyte proliferation.
Dig Liver Dis
2009

Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.
Int. J. Cancer
2009;125;3

Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
Liver Int.
2009;29;7

Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1.
Am. J. Physiol. Gastrointest. Liver Physiol.
2009;297;1
[ See timeline ] [ See all publications ]
means that Onori, Paolo has 13 papers cited a least 13 times - methodology
Department of Medicine, Scott & White Hospital, Texas A&M Health Science Center College of Medicine, Temple, TX 76504, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.